Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 2.50 (10.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.40
Prev. Close: 25.00
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Feb 2024 07:00

RNS Number : 8380D
KRM22 PLC
21 February 2024
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Trading Update

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, today announces the following trading update.

 

The Company is executing on its plan to increase the value of its Annual Recurring Revenue ("ARR") to £10m through the development of new products, leveraging the distribution reach of key partners and realising new business from a growing pipeline of new prospects. 

 

At the date of this announcement, the Company's ARR stands at £5.8m (£4.6m at 31 December 2022). The continued growth in ARR has come from a revived product suite including multi-year contracts for Risk Manager, Limits Manager and Market Surveillance via direct sales and sales from distributors including Trading Technologies International, Inc. ("TT") under the terms of the distribution agreement with TT signed in December 2021.

 

The underlying cost base of the business continues to be tightly managed and, following a careful review by the Board, management have taken a decision to implement a focused cost saving program with annual cost savings of approximately £1.2m early in the current financial year. The cost savings are expected to accelerate the Company's path to profitability, whilst having minimal impact on operations as the savings have come from staff redundancies in roles where operational synergies can be achieved and a reduction in contracted development resources as specific projects are nearing completion.

 

The growth in ARR, together with the continued management of the underlying cost base of the business and the availability of funds to drawdown from the TT debt facility means that the Company expects to operate within its existing available cash and facilities and anticipated new contract signings.

 

The Company expects to report audited results for the 12-month period to 31 December 2023 ("FY2023") in May 2024, and the financial highlights* include:

 

· Gross cash as of 31 December 2023 of £0.9m (FY2022: £1.9m)

· ARR of 31 December 2023 of £5.4m (FY2022: £4.6m at constant FX rates) - growth of 17.4%

New contracted ARR in the year of £1.1m (FY2022: £1.3m)

· Total revenue recognised of approximately £5.2m (FY2022: £4.3m) - growth of 20.9%

· Net debt at 31 December 2023 of £3.6m with the Company having drawn down a total of £4.5m on the debt facility with TT announced on 19 June 2023 with £0.5m remaining undrawn.

 

Stephen Casner, CEO at KRM22 commented: "Our continued growth reflects the persistent demand that the derivatives market has for KRM22's next generation of risk management systems. In the last few months we have added three new FCMs, including one top 10 FCM, to KRM22's risk platform. Our pipeline of new sales opportunities remains strong and we expect further announcements detailing additional FCM's committing to our Limits Manager product in H1 2024. The Company expects current cash and the debt facility to provide sufficient runway to a cash flow positive position and is looking to resume market forecasts upon release of audited financials in May 2024."

 

\* The financial expectations noted above are preliminary, and subject to year-end financial close and audit review processes.

 

 

For further information please contact:

 

KRM22 plc

Keith Todd CBE, Executive Chairman

Stephen Casner, CEO

Kim Suter, CFO

 

InvestorRelations@krm22.com

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Carl Holmes / George Dollemore (Corporate Finance)

Sunila de Silva (ECM)

 

+44 (0)20 7220 0500

 

 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSELEFSELSEIE
Date   Source Headline
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting
21st Jul 20237:00 amRNSDirector Dealing
20th Jul 20237:00 amRNSHalf Year Trading Update
4th Jul 20237:00 amRNSPosting of Accounts, Circular and Notice of GM
30th Jun 202312:41 pmRNSResult of AGM
27th Jun 20237:00 amRNSFinal Results
19th Jun 20237:00 amRNSNew Debt Facility
8th Jun 20237:00 amRNSAnnual Report and Notice of AGM
16th Dec 20223:15 pmRNSIssue of Options
20th Sep 20227:00 amRNSInterim Results
13th Jun 202210:00 amRNSHolding(s) in Company
5th May 202212:00 pmRNSResult of AGM
20th Apr 20222:30 pmRNSDirector Dealing
12th Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
7th Apr 20224:30 pmRNSHolding(s) in Company
28th Mar 20225:30 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSProduct Launch Under Distribution Agreement
1st Mar 20227:00 amRNSUpdate re Annual Results (Change of Date)
31st Jan 20227:00 amRNSTrading Update
5th Jan 202210:47 amRNSHolding(s) in Company
30th Dec 20219:47 amRNSSubscription Completion, Executive Changes and TVR
22nd Dec 20217:00 amRNSSubscription Update
22nd Nov 20217:00 amRNSHolding(s) in Company
1st Nov 20217:00 amRNSSubscription Agreement and Trading Update
20th Oct 20213:43 pmRNSHolding(s) in Company
16th Sep 20212:38 pmRNSDirector/PDMR Shareholding
13th Sep 20219:52 amRNSDirector/PDMR Shareholding
10th Sep 20212:48 pmRNSDirector/PDMR Shareholding
8th Sep 202112:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNSInterim Results
30th Jul 20217:00 amRNSContract Extension
22nd Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20217:00 amRNSKRM22 announces partnership with Waymark Tech
28th Apr 20211:29 pmRNSResult of AGM
19th Apr 20217:00 amRNSExercise of options and total voting rights
26th Mar 20213:24 pmRNSHolding(s) in Company
23rd Mar 20218:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20215:39 pmRNSHolding(s) in Company
16th Mar 202111:06 amRNSTechnology Demonstration
16th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSKRM22 announces new partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.